Quris AI | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Quris AI is an artificial intelligence company dedicated to enhancing the drug development process. Its main product, the Bio-AI Clinical Prediction Platform, combines machine learning with experimental data from miniaturized human organ systems, known as "patients-on-a-chip." This innovative platform aims to predict the safety and efficacy of drug candidates, helping to lower the high failure rates in clinical trials and reduce development costs and timelines.

Headquartered in Boston and Tel Aviv, the organization is led by a team of experts in various fields, including machine learning and medical device development. It collaborates with major pharmaceutical firms, such as Merck KGaA, to improve early-stage safety predictions and streamline drug safety evaluations. Quris AI is committed to ethical standards and has secured significant funding to support its mission of delivering safe and effective drugs to patients.